Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.69M Sell
97,335
-73,605
-43% -$1.63M ﹤0.01% 2703
2026
Q1
$2.5M Buy
170,940
+34,052
+25% +$500K ﹤0.01% 2525
2025
Q4
$1.73M Buy
136,888
+88,646
+184% +$1.31M ﹤0.01% 2751
2025
Q3
$742K Sell
48,242
-86,095
-64% -$1.39M ﹤0.01% 3359
2025
Q2
$2.11M Sell
134,337
-81,496
-38% -$1.24M ﹤0.01% 2596
2025
Q1
$4.12M Sell
215,833
-125,131
-37% -$2.74M ﹤0.01% 2075
2024
Q4
$8.13M Buy
340,964
+144,216
+73% +$4.03M ﹤0.01% 1538
2024
Q3
$5.51M Buy
196,748
+112,073
+132% +$3.17M ﹤0.01% 1768
2024
Q2
$2.21M Buy
84,675
+6,383
+8% +$133K ﹤0.01% 2266
2024
Q1
$1.71M Buy
78,292
+8,289
+12% +$178K ﹤0.01% 2563
2023
Q4
$1.63M Buy
70,003
+23,943
+52% +$482K ﹤0.01% 2416
2023
Q3
$909K Sell
46,060
-48,307
-51% -$951K ﹤0.01% 2598
2023
Q2
$2.14M Buy
94,367
+30,580
+48% +$616K ﹤0.01% 2154
2023
Q1
$1.25M Buy
63,787
+33,767
+112% +$648K ﹤0.01% 2385
2022
Q4
$516K Buy
+30,020
New +$533K ﹤0.01% 3144

Other funds holding RXO

Citigroup's RXO Position: Q2 2026 in Review

Citigroup reduced its RXO (RXO) stake by 43% in Q2 2026, selling an estimated $1.63M and leaving 97,335 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

Citigroup first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.13M in Q4 2024. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Citigroup held 97,335 shares of RXO worth $2.69M as of Q2 2026.
  • Citigroup sold 73,605 RXO shares in Q2 2026, an estimated $1.63M.
  • RXO made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2703 holding.
  • Citigroup first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Citigroup's RXO position peaked at $8.13M in Q4 2024.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.